Quest Diagnostics (DGX)
(Delayed Data from NYSE)
$153.08 USD
-0.90 (-0.58%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $153.07 -0.01 (-0.01%) 7:18 PM ET
2-Buy of 5 2
B Value C Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Quest Diagnostics Incorporated falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 908.00 | 1,015.00 | 2,080.00 | 1,499.00 | 906.00 |
Depreciation/Amortization & Depletion | 439.00 | 437.00 | 408.00 | 361.00 | 329.00 |
Net Change from Assets/Liabilities | -145.00 | 119.00 | 87.00 | 22.00 | 35.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 70.00 | 147.00 | -342.00 | 123.00 | -27.00 |
Net Cash From Operating Activities | 1,272.00 | 1,718.00 | 2,233.00 | 2,005.00 | 1,243.00 |
Property & Equipment | -408.00 | -404.00 | -403.00 | -418.00 | -400.00 |
Acquisition/ Disposition of Subsidiaries | -611.00 | -144.00 | 424.00 | -330.00 | -58.00 |
Investments | -42.00 | 5.00 | -3.00 | -27.00 | -44.00 |
Other Investing Activities | 0.00 | 0.00 | 3.00 | 3.00 | 91.00 |
Net Cash from Investing Activities | -1,061.00 | -543.00 | 21.00 | -772.00 | -411.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -203.00 | -1,285.00 | -2,070.00 | -136.00 | -234.00 |
Issuance (Repayment) of Debt | 748.00 | -2.00 | -2.00 | -805.00 | 832.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -314.00 | -305.00 | -309.00 | -297.00 | -286.00 |
Other Financing Activities | -71.00 | -140.00 | -159.00 | -29.00 | -87.00 |
Net Cash from Financing Activities | 160.00 | -1,732.00 | -2,540.00 | -1,267.00 | 225.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 371.00 | -557.00 | -286.00 | -34.00 | 1,057.00 |
Cash at Beginning of Period | 315.00 | 872.00 | 1,158.00 | 1,192.00 | 135.00 |
Cash at End of Period | 686.00 | 315.00 | 872.00 | 1,158.00 | 1,192.00 |
Diluted Net EPS | 7.49 | 7.97 | 15.55 | 10.47 | 6.28 |
Fiscal Year End for Quest Diagnostics Incorporated falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 448.00 | 208.00 | 908.00 | 703.00 | 466.00 |
Depreciation/Amortization & Depletion | 233.00 | 116.00 | 439.00 | 330.00 | 219.00 |
Net Change from Assets/Liabilities | -192.00 | -186.00 | -145.00 | -319.00 | -171.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 25.00 | 16.00 | 70.00 | 31.00 | 24.00 |
Net Cash From Operating Activities | 514.00 | 154.00 | 1,272.00 | 745.00 | 538.00 |
Property & Equipment | -196.00 | -104.00 | -408.00 | -336.00 | -231.00 |
Acquisition/ Disposition of Subsidiaries | -248.00 | -142.00 | -611.00 | -611.00 | -609.00 |
Investments | 0.00 | 0.00 | -42.00 | 0.00 | 0.00 |
Other Investing Activities | 31.00 | 33.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -413.00 | -213.00 | -1,061.00 | -947.00 | -840.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 28.00 | 12.00 | -203.00 | 60.00 | 47.00 |
Issuance (Repayment) of Debt | -301.00 | 0.00 | 748.00 | 277.00 | 319.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -181.00 | -79.00 | -314.00 | -234.00 | -154.00 |
Other Financing Activities | -62.00 | -86.00 | -71.00 | -73.00 | -99.00 |
Net Cash from Financing Activities | -516.00 | -153.00 | 160.00 | 30.00 | 113.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -415.00 | -212.00 | 371.00 | -172.00 | -189.00 |
Cash at Beginning of Period | 686.00 | 686.00 | 315.00 | 315.00 | 315.00 |
Cash at End of Period | 271.00 | 474.00 | 686.00 | 143.00 | 126.00 |
Diluted Net EPS | 2.03 | 1.72 | 1.70 | 1.96 | 2.05 |